12/06/2008

ERYtech Pharma US Office

ERYtech Pharma establishes in the USA and selects the Philadelphia Science Center as US Headquarters. Learn more

11/06/2008

Bio 2008, June 17-20 - San Diego

03/06/2008

EHA - Copenhagen - June 12/15 2008

13/05/2008

ERYtech Pharma will be present on ILSI BioMed 2008 – Tel-Aviv

28/04/2008

ERYtech Pharma reinforces its Management Team

ERYtech Pharma reinforces its Management Team with Dr David Liens as CMO and Philippe Dujardin as CFO and has appointed Dr Véronique Sézanne as the Qualified PersonLearn more

25/04/2008

5th Annual Healthcare Conference Rodman & Renshaw - Monte Carlo, May 19-20

Learn more

25/04/2008

EPIC Biotech 2008 - London - May 22

28/03/2008

BIO-Europe Spring 2008, Madrid - April 7-9

28/03/2008

FABS and FABZ - La Jolla April 1-4, 2008

06/02/2008

ERYtech Pharma will present two posters at the Acute Leukemias XII Symposium, in Munich, Germany February 16-20, 2008

06/02/2008

ERYtech Pharma is selected for an Oral Presentation at The Acute Leukemias XII Symposium in Munich, Germany - February 16-20, 2008

28/01/2008

ERYtech Pharma will present a poster at The Lysosomal Disease Network - Las Vegas - February 13-15, 2008

20/12/2007

BIO-Asia 2008

29/11/2007

ERYtech Pharma is very proud to announce Pr. Jacques DESCOTES, joins the Scientific Committee.

ERYtech Pharma is very proud to announce Pr. Jacques DESCOTES, M.D., Pharm.D., Ph.D. joins the Scientific Committee.Learn more

27/11/2007

ASH in Atlanta on December 7-11, 2007.

ERYtech Pharma will be present at the ASH in Atlanta on December 7-11, 2007.Learn more

07/11/2007

New address

ERYtech Pharma transfers all its Office and facilities Learn more

24/10/2007

Véronique Sézanne joins ERYtech Pharma as Regulatory Affairs Director

Véronique Sézanne, PharmD, joins ERYtech Pharma as Regulatory Affairs Director. Learn more

24/10/2007

Bio Europe - Hamburg

ERYtech Pharma will attend the Bio Europe Convention in Hamburg, Learn more

27/07/2007

Press Release, July 2007

Lyon, (France), July, 16th 2007 – ERYtech Pharma strengthens its Team and starts its international development.Learn more

30/03/2007

Bio- Boston

ERYtech Pharma will attend the Bio International Convention in Boston- MA on May 6-9 2007.Learn more

21/03/2007

Poster SFH

ERYtech Pharma will present a poster ''Encapsulation de L-Asparaginase dans les Erythrocytes - Principe et Intérêts'' Y. Godfrin and Y. Bertrand, on the SFH - March 22-24 2007 at the Maison de la Chimie, Paris.Learn more

19/01/2007

ERYtech Pharma raises €12 million to boost its development.

Lyon, (France), 22 December 2006 – ERYtech Pharma, the biotech company specialized in red blood cell encapsulation of drugs, is pleased to announce the successful completion of a €12 million fund-raising. This round brings together AGF Private Equity (Thierry Laugel), Auriga Partners (Franck Lescure) and AXA Private Equity (Glenn Richard) along with its original investors, including CapDecisif (Jérôme Snollaerts) and Amorçage Rhône Alpes (Karine Lignel).Learn more

05/10/2006

GRASPA® RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION

ERYTECH PHARMA, a biopharmaceutical company specialized in the encapsulation of therapeutic molecules and enzymes into Red Blood Cells, today announced that the Innovation Task Force (ITF), a division of the European Medicines Agency (EMEA) has approved regulatory classification for GRASPA® (L-Asparaginase encapsulated in Erythrocyte) as medicinal product, eligible for EMEA procedures. Learn more

22/06/2006

Lyon, June 2006

ERYtech Pharma announces that his surface of laboratory has been increased threefold...Learn more

17/01/2006

Meet ERYtech Pharma at major international events

ERYtech Pharma's representatives will attend major biotech and life sciences events in the forthcoming months...Learn more

02/01/2006

ERYtech Pharma welcomes new colleagues and opens an office in Paris

ERYtech Pharma's team enlarges to 8 people as it welcomes two new members, Thomas Vigneron as Projects & Quality Manager, and David Salako as Clinical Affairs Manager ...Learn more

03/11/2005

ERYtech Pharma achieves its fund raising and starts a Phase II clinical trial

ERYtech Pharma, a French biopharmaceutical company specialized in the encapsulation of therapeutic molecules into red blood cells, announces today the closing of its first financing round...Learn more

30/06/2005

ERYtech Pharma and the anticancer Centre Léon Bérard sign a five year R&D partnership

ERYtech Pharma announces the renewal of its partnering convention with the Centre Léon Bérard for another five years ...Learn more

29/06/2005

ERYtech Pharma receives an award from the French Ministry of Research

ERYtech Pharma has been granted an award from the French Ministry of Research for its innovative activity and technology ...Learn more

02/11/2004

The biotechnology company ERYtech Pharma is officially founded

The French biotechnology ERYtech Pharma announces today its official foundation. After a period of incubation in Crealys, the ERYtech Pharma project has now turned into a promising company...Learn more

30/06/2004

The ERYtech Pharma project receives an award from the French Ministry of Research

ERYtech Pharma has been granted a 40 000 euro award from the French Ministry of Research ...Learn more

01/06/2004

The ERYtech Pharma project starts its incubation phase at Crealys

The ERYtech Pharma project, based on the encapsulation of therapeutic molecules or enzymes into red blood cells...Learn more